11/06/2024 11:14 AM | Iradimed (Subject) VUOTO ANTHONY (Reporting)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
10/31/2024 3:15 PM | Iradimed (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
10/31/2024 7:00 AM | Iradimed (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
10/22/2024 2:24 PM | BlackRock, Inc. (Filed by) Iradimed (Subject)
| Form SC 13G | |
10/15/2024 4:45 PM | Iradimed (Issuer) Scharen-Guivel Hilda Frederique (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
08/01/2024 3:30 PM | Iradimed (Filer)
| Form 10-Q General form for quarterly reports under Section 13 or 15(d) | |
08/01/2024 7:30 AM | Iradimed (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
|
06/07/2024 7:30 AM | Iradimed (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
06/04/2024 4:15 PM | ALLEN MONTY K (Reporting) Iradimed (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
06/03/2024 9:40 AM | ALLEN MONTY K (Reporting) Iradimed (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
06/03/2024 7:30 AM | Iradimed (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
05/09/2024 8:16 AM | Iradimed (Filer)
| Form ARS | |
05/08/2024 11:15 PM | Iradimed (Filer)
| Form EFFECT | |
05/02/2024 7:30 AM | Iradimed (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
03/01/2024 7:30 AM | Iradimed (Filer)
| Form 10-K Annual report pursuant to Section 13 or 15(d) | |
02/12/2024 11:03 AM | Iradimed (Subject) Nine Ten Capital Management LLC (Filed by)
| Form SC 13G/A | |
02/08/2024 7:05 AM | Iradimed (Filer)
| Form 8-K Current report pursuant to Section 13 or 15(d) | |
02/02/2024 8:44 AM | Iradimed (Subject) Soleus Capital Master Fund, L.P. (Filed by)
| Form SC 13G/A | |
12/27/2023 5:30 PM | Iradimed (Issuer) Susi Roger E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/22/2023 4:15 PM | Iradimed (Issuer) Susi Roger E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 7:05 PM | HAWKINS JAMES B (Reporting) Iradimed (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/14/2023 3:34 PM | HAWKINS JAMES B (Reporting) Iradimed (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/13/2023 4:15 PM | HAWKINS JAMES B (Reporting) Iradimed (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/12/2023 4:30 PM | HAWKINS JAMES B (Reporting) Iradimed (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/11/2023 5:00 PM | HAWKINS JAMES B (Reporting) Iradimed (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 5:00 PM | ALLEN MONTY K (Reporting) Iradimed (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 5:00 PM | Iradimed (Issuer) VUOTO ANTHONY (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 5:00 PM | Iradimed (Issuer) Scharen-Guivel Hilda Frederique (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/11/2023 5:00 PM | GLENN JOHN (Reporting) Iradimed (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/06/2023 3:05 PM | Iradimed (Issuer) Susi Roger E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/05/2023 3:30 PM | HAWKINS JAMES B (Reporting) Iradimed (Issuer)
| Form 4 Statement of changes in beneficial ownership of securities | |
12/04/2023 7:00 PM | HAWKINS JAMES B (Reporting) Iradimed (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 7:32 PM | HAWKINS JAMES B (Reporting) Iradimed (Subject)
| Form 144 Notice of proposed sale of securities pursuant to Rule 144 | |
12/01/2023 3:05 PM | Iradimed (Issuer) Susi Roger E. (Reporting)
| Form 4 Statement of changes in beneficial ownership of securities | |